Dr. Timos Papagatsias’ Post

View profile for Dr. Timos Papagatsias, graphic

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines

Thoughts on this? >> FDA gives accelerated approval to PBC drug at the center of Gilead’s $4.3B CymaBay deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #pharmaceutical #productmarketing

Gilead wins FDA accelerated approval of seladelpar after acquiring it in $4.3B deal

Gilead wins FDA accelerated approval of seladelpar after acquiring it in $4.3B deal

endpts.com

To view or add a comment, sign in

Explore topics